Elevation Wealth Partners’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
Elevation Wealth Partners's OGN Position: Q3 2026 in Review
Elevation Wealth Partners reduced its Organon & Co (OGN) stake by 3.5% in Q3 2026, selling an estimated $259 and leaving 526 shares worth $7.21K. The position accounts for ﹤0.01% of the portfolio, ranked #1012.
Elevation Wealth Partners first reported a position in OGN in Q1 2023 and has held it in 15 quarters since. The position peaked at $8.57K in Q4 2025. 205 funds tracked by Wall St. Rank hold OGN as of Q3 2026.
- Elevation Wealth Partners held 526 shares of Organon & Co worth $7.21K as of Q3 2026.
- Elevation Wealth Partners sold 19 Organon & Co shares in Q3 2026, an estimated $259.
- Organon & Co made up ﹤0.01% of Elevation Wealth Partners's portfolio in Q3 2026, its #1012 holding.
- Elevation Wealth Partners first reported a position in Organon & Co in Q1 2023 and has held it in 15 quarters since.
- Elevation Wealth Partners's Organon & Co position peaked at $8.57K in Q4 2025.
- 205 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.
Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.